LEA LEIV

CIK 00009390122 companiesBURLINGAME, CA

SEC Profile

Transactions

Companies

Filings

CIK

0000939012

Recent Transactions

26 trades

Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2025-12-04+400,000→ 400,000 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2024-12-20+300,000→ 300,000 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2023-12-06+200,000→ 200,000 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-12-14$0.84/sh+4,000→ 133,238 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-12-13$0.74/sh+30,000→ 129,238 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2022-08-11+160,000→ 160,000 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-03-17$1.65/sh+13,878→ 99,238 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2022-03-16$1.54/sh+35,160→ 85,360 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2021-09-09+160,000→ 160,000 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2020-12-16+160,000→ 160,000 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2019-12-12+160,000→ 160,000 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2019-06-07$3.38/sh+10,000→ 50,200 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2019-06-06$3.56/sh+15,500→ 40,200 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2018-12-21$4.15/sh+24,700→ 24,700 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2018-12-12+100,000→ 100,000 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2017-12-13+40,000→ 40,000 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2016-12-07+25,000→ 25,000 total
Gift
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2016-08-25−48,000→ 151,253 total
Gift
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2016-08-25−2,047→ 149,206 total
Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Series A Preferred Stock
2016-03-29−42,608→ 0 total
Conversion
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock, $0.0001 par value
2016-03-29+42,608→ 199,253 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2016-03-22+60,000→ 60,000 total
Other
PHARMACYCLICS INC
Common Stock
2006-04-28$4.87/sh+1,000→ 7,893 total
Award
PHARMACYCLICS INC
Employee Stock Option (right to by)
2005-06-03+60,000→ 60,000 total
Other
PHARMACYCLICS INC
Common Stock
2005-04-29$4.93/sh+1,000→ 5,893 total
Purchase
PHARMACYCLICS INC
Common Stock
2003-10-30$4.79/sh+270→ 2,216 total

Companies

Recent Filings

Address

C/O CORVUS PHARMACEUTICALS, INC. 863 MITTEN ROAD, SUITE 102

BURLINGAME, CA, 94010

View on SEC.gov